History and beginnings
The driving force behind the first ANZMIG meeting in 1997 was Cryptococcus gattii epidemiology, another fungus well known in Australia was also described 5 . Important prognostic factors were identified for the first time and treatment responses characterised 5 .
Although not ANZMIG studies, two successful NHMRC grants entailing several million dollars evolved from the ANZMIG collaborations:
one a randomised trial of Aspergillus PCR and galactomannan (GM)
as early diagnosis for aspergillosis in high risk haematology patients compared to standard diagnostic methods 6 . This study showed the safety of this approach. A second grant related to risk prediction for candidemia in the ICU is ongoing. Australian and New Zealand mycology suffers the same underfunding and low profile described Under the Microscope MICROBIOLOGY AUSTRALIA * MAY 2015
